ATE359519T1 - Diagnostisches verfahren für chronische obstruktive lungen krankheit - Google Patents

Diagnostisches verfahren für chronische obstruktive lungen krankheit

Info

Publication number
ATE359519T1
ATE359519T1 AT00931424T AT00931424T ATE359519T1 AT E359519 T1 ATE359519 T1 AT E359519T1 AT 00931424 T AT00931424 T AT 00931424T AT 00931424 T AT00931424 T AT 00931424T AT E359519 T1 ATE359519 T1 AT E359519T1
Authority
AT
Austria
Prior art keywords
chronic obstructive
lung disease
diagnostic procedure
obstructive lung
cadherin
Prior art date
Application number
AT00931424T
Other languages
English (en)
Inventor
Michael Robert West
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE359519T1 publication Critical patent/ATE359519T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G01N2800/122—Chronic or obstructive airway disorders, e.g. asthma COPD
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00931424T 1999-05-29 2000-05-25 Diagnostisches verfahren für chronische obstruktive lungen krankheit ATE359519T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9912534.6A GB9912534D0 (en) 1999-05-29 1999-05-29 Novel prognostic surrogate

Publications (1)

Publication Number Publication Date
ATE359519T1 true ATE359519T1 (de) 2007-05-15

Family

ID=10854409

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00931424T ATE359519T1 (de) 1999-05-29 2000-05-25 Diagnostisches verfahren für chronische obstruktive lungen krankheit

Country Status (8)

Country Link
US (1) US6929920B1 (de)
EP (1) EP1181558B1 (de)
AT (1) ATE359519T1 (de)
AU (1) AU4937800A (de)
DE (1) DE60034334T2 (de)
ES (1) ES2284498T3 (de)
GB (1) GB9912534D0 (de)
WO (1) WO2000073803A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2141499A1 (de) 2008-07-02 2010-01-06 Apoptec AG COPD-Diagnose
US9207242B2 (en) 2008-10-09 2015-12-08 The University Of Hong Kong Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
CN105588944B (zh) * 2016-02-25 2017-05-24 首都医科大学附属北京胸科医院 检测agp1、serpina3和cdh1含量的系统在筛查活动性结核病患者中的应用
RU2652550C1 (ru) * 2017-11-28 2018-04-26 федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации (ФГБОУ ВО ВГМУ им. Н.Н. Бурденко Минздрава России) Способ прогнозирования обострений хронической обструктивной болезни легких у пациентов с ожирением

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5597725A (en) 1992-04-17 1997-01-28 Doheny Eye Institute Cadherin-specific antibodies and hybridoma cell lines
JP3165828B2 (ja) 1993-03-18 2001-05-14 寳酒造株式会社 悪性腫瘍の検出方法及びキット
DE69735225T2 (de) 1996-08-28 2006-11-02 Affinium Pharmaceuticals, Inc., Toronto Fab I Enoyl-ACP-Reduktase aus Staphylokokken
US5895748A (en) 1996-11-27 1999-04-20 Johnson; Keith R. Panel of antibodies for detecting cadherins and catenins in tissues and method of using the panel of antibodies
SE9801368D0 (sv) 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
GB9912534D0 (en) 1999-07-28
DE60034334D1 (de) 2007-05-24
US6929920B1 (en) 2005-08-16
WO2000073803A1 (en) 2000-12-07
DE60034334T2 (de) 2007-12-27
EP1181558A1 (de) 2002-02-27
EP1181558B1 (de) 2007-04-11
ES2284498T3 (es) 2007-11-16
AU4937800A (en) 2000-12-18

Similar Documents

Publication Publication Date Title
ATE315789T1 (de) Elisa für vegf
ATE312946T1 (de) Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten
NO20076656L (no) Forbedrede immunoassay metoder
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
ATE423217T1 (de) Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten
DE60138829D1 (de) Verfahren zur unterscheidung des reizkolons von der entzündlichen darmerkrankung (inflammatory bowel disease, ibd) und zur überwachung von patienten mit ibd unter verwendung von endogenem gesamt-lactoferrin als marker
CA2384579A1 (en) Early cancer tumor marker
MY133942A (en) Reagent test strip for analyte determination having hemolyzing agent
GB2413078B (en) A system or method for assessing a subject's pedal blood circulation
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
DE68925058D1 (de) Verfahren zum frühzeitigen Nachweis von Lungenkrebs
JP2020519904A5 (de)
ATE529743T1 (de) Verfahren und kits zur tumorigenizitätsdiagnose
DE60034334D1 (de) Diagnostisches verfahren für chronische obstruktive lungen krankheit
RU2008103988A (ru) Способ диагностики рассеяного склероза
ATE262179T1 (de) Verfahren zum nachweis von alpha-oxoaldehyden in vollblut, blutplasma und/oder serum eines patienten
DE60112949D1 (de) Verfahren zum nachweis eines lipoprotein-akutphaseprotein-komplexes
ATE272215T1 (de) Verfahren zur diagnose von sepsis unter bestimmung von ca 19-9
ATE293794T1 (de) Verfahren zur diagnose von sepsis unter bestimmung von ca 125
WO2001093762A3 (en) A fail-sure computer aided method for anticoagulant treatment
ES2099876T3 (es) Procedimiento para la determinacion de anticuerpos de lupus anticoagulante que provocan trombosis.
WO1998046993A3 (en) Method for diagnosing cancer by measuring the presence of creatine kinase inhibitor
DE60039756D1 (de) Diagnostisches verfahren für nierenkrankheiten in menschen
ATE209359T1 (de) Bestimmung von freiem und komplexiertem trypsinogen-2
DE602005023973D1 (de) Verfahren zur diagnose von chronischem stress und verwandten erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties